Patent application number | Description | Published |
20100130426 | COMPOSITIONS CONTAINING SATIOGENS AND METHODS OF USE - Provided herein are methods and compositions for treating metabolic diseases and conditions associated with metabolic diseases. | 05-27-2010 |
20100130472 | BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF OBESITY AND DIABETES - Provided herein are methods of utilizing bile acid transport inhibitors for the treatment of obesity and diabetes. | 05-27-2010 |
20110136737 | DPP-IV Resistant GIP Hybrid Polypeptides with Selectable Properties - The Present invention relates generally to novel GIP analogs and GIP hybrid polypeptides with selectable properties, useful as agents for the treatment and prevention of metabolic diseases and disorders, for example those which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, positive inotropic effects, reduction of catabolic effects, slowing of gastric emptying. Such conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, critical care, insulin-resistance, obesity, and diabetes mellitus of any kind, including type 1, type 2, and gestational diabetes. | 06-09-2011 |
20110294767 | BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS - Provided herein are methods of utilizing bile acid transport inhibitors and/or enteroendocrine peptide enhancing agents for the treatment of obesity, diabetes, and inflammatory gastrointestinal conditions. | 12-01-2011 |
20120157399 | BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF OBESITY AND DIABETES - Provided herein are methods of utilizing bile acid transport inhibitors for the treatment of obesity and diabetes. | 06-21-2012 |
20130023466 | Peptide YY and Peptide YY Agonists for Treatment of Metabolic Disorders - Methods and compositions are disclosed to treat metabolic disorders such as obesity, diabetes, and increased cardiovascular risk comprising administering a therapeutically effective amount of a PYY or a PYY agonist. | 01-24-2013 |
20130059807 | BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS - Provided herein are methods of utilizing bile acid transport inhibitors and/or enteroendocrine peptide enhancing agents for the treatment of obesity, diabetes, and inflammatory gastrointestinal conditions. | 03-07-2013 |
20130090590 | Methods and Apparatus for Treating Obesity and Diabetes - Provided herein are methods and shunt devices for treating diabetes and obesity. Methods and shunt devices promote stimulation of secretion of intestinal L-cells and other enteroendocrine cell types. Enteroendocrine secretion is stimulated directly or indirectly by shunting bile and/or pancreatic secretion to segments of the gut more distal than would normally occur. The shunt device may be a flexible catheter that is impervious to such secretions, with a proximal end draining the pancreatic/bile duct, and a distal end residing distally within the lumen of the small or large intestine. The shunt may be inserted with minimally invasive techniques, such as by endoscopy or laparoscopy. | 04-11-2013 |
20130190281 | Compositions Containing Satiogens and Methods of Use - Provided herein are methods and compositions for treating metabolic diseases and conditions associated with metabolic diseases. | 07-25-2013 |
20130281374 | DPP-IV RESISTANT GIP HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES - The present invention relates generally to novel GIP analogs and GIP hybrid polypeptides with selectable properties, useful as agents for the treatment and prevention of metabolic diseases and disorders, for example those which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, positive inotropic effects, reduction of catabolic effects, slowing of gastric emptying. Such conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, critical care, insulin-resistance, obesity, and diabetes mellitus of any kind, including type 1, type 2, and gestational diabetes. | 10-24-2013 |
20140135261 | PEPTIDE YY AND PEPTIDE YY AGONISTS FOR TREATMENT OF METABOLIC DISORDERS - Methods and compositions are disclosed to treat metabolic disorders such as obesity, diabetes, and increased cardiovascular risk comprising administering a therapeutically effective amount of a PYY or a PYY agonist. | 05-15-2014 |
20150087642 | BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS - Provided herein are methods of utilizing bile acid transport inhibitors and/or enteroendocrine peptide enhancing agents for the treatment of obesity, diabetes, and inflammatory gastrointestinal conditions. | 03-26-2015 |
Patent application number | Description | Published |
20110034377 | Exendin and Exendin Agonists for Eating Disorders - Methods for treating conditions or disorders which can be alleviated by reducing food intake are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist, alone or in conjunction with other compounds or compositions that affect satiety. The methods are useful for treating conditions or disorders, including obesity, Type II diabetes, eating disorders, and insulin-resistance syndrome. The methods are also useful for lowering the plasma glucose level, lowering the plasma lipid level, reducing the cardiac risk, reducing the appetite, and reducing the weight of subjects. Pharmaceutical compositions for use in the methods of the invention are also disclosed. | 02-10-2011 |
20110195904 | METHODS OF TREATMENT USING EXENDIN PEPTIDES OR GLP-1 PEPTIDES - Methods for increasing urine flow are disclosed, comprising administration of an effective amount of GLP-1, an exendin, or an exendin or GLP-1 agonist. Methods for increasing urinary sodium excretion and decreasing urinary potassium concentration are also disclosed. The methods are useful for treating conditions or disorders associated with toxic hypervolemia, such as renal failure, congestive heart failure, nephrotic syndrome, cirrhosis, pulmonary edema, and hypertension. The present invention also relates to methods for inducing an inotropic response comprising administration of an effective amount of GLP-1, an exendin, or an exendin or GLP-1 agonist. These methods are useful for treating conditions or disorders that can be alleviated by an increase in cardiac contractility such as congestive heart failure. Pharmaceutical compositions for use in the methods of the invention are also disclosed. | 08-11-2011 |
20110281798 | Methods for Lowering Plasma Glucagon with Exendins and Exendin Agonist Analogs - Novel formulations containing exendins, exendin agonists and/or exendin analogs are provided. | 11-17-2011 |
20110288028 | AMYLIN AND AMYLIN AGONISTS FOR TREATING PSYCHIATRIC DISEASES AND DISORDERS - Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders. | 11-24-2011 |
20120004168 | EXENDINS AND EXENDIN AGONIST ANALOGS TO REGULATE GASTROINTESTINAL MOTILITY - Methods for reducing gastric motility and delaying gastric emptying for therapeutic and diagnostic purposes are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist. Methods for treating conditions associated with elevated, inappropriate, or undesired post-prandial blood glucose levels are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist alone or in conjunction with other anti-gastric emptying agents. | 01-05-2012 |
20120135922 | MODIFIED EXENDINS AND EXENDIN AGONISTS - Novel modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonists, compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake. | 05-31-2012 |
20130023470 | EXENDIN AND EXENDIN AGONISTS FOR EATING DISORDERS - Methods for treating conditions or disorders which can be alleviated by reducing food intake are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist, alone or in conjunction with other compounds or compositions that affect satiety. The methods are useful for treating conditions or disorders, including obesity, Type II diabetes, eating disorders, and insulin-resistance syndrome. The methods are also useful for lowering the plasma glucose level, lowering the plasma lipid level, reducing the cardiac risk, reducing the appetite, and reducing the weight of subjects. Pharmaceutical compositions for use in the methods of the invention are also disclosed. | 01-24-2013 |
20130165379 | Formulations of Exendins and Exendin Agonist Analogs - Provided herein are formulations containing exendins, exendin, agonists and/or exendin analogs and methods of using the exendins, exendin agonists and/or exendin analogs and formulations thereof to treat glucagonoma and necrolytic migratory erythema, or to suppress glucagon secretion. | 06-27-2013 |
20130184213 | Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders - Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders. | 07-18-2013 |
20130331322 | EXENDINS AND EXENDIN AGONIST ANALOGS TO REGULATE GASTROINTESTINAL MOTILITY - Methods for reducing gastric motility and delaying gastric emptying for therapeutic and diagnostic purposes are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist. Methods for treating conditions associated with elevated, inappropriate, or undesired post-prandial blood glucose levels are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist alone or in conjunction with other anti-gastric emptying agents. | 12-12-2013 |
20140038891 | MODIFIED EXENDINS AND EXENDIN AGONISTS - Novel modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonists, compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake. | 02-06-2014 |
20150080307 | EXENDINS AND EXENDIN AGONIST ANALOGS TO REGULATE GASTROINTESTINAL MOTILITY - Methods for reducing gastric motility and delaying gastric emptying for therapeutic and diagnostic purposes are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist. Methods for treating conditions associated with elevated, inappropriate, or undesired post-prandial blood glucose levels are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist alone or in conjunction with other anti-gastric emptying agents. | 03-19-2015 |
20150080308 | Formulations and Uses of Exendins and Exendin Agonist Analogs - Provided herein are formulations containing exendins, exendin agonists and/or exendin analogs and methods of using the exendins, exendin agonists and/or exendin analogs and formulations thereof to treat glucagonoma and necrolytic migratory erythema, or to suppress glucagon secretion. | 03-19-2015 |
Patent application number | Description | Published |
20150186233 | REMOTE DIAGNOSTICS FOR A COMPUTING DEVICE - For remote diagnostics of a computing device, a method is disclosed that includes collecting failure information from a computing device, wherein the computing device has an error, encapsulating the failure information into a file, and transmitting the file from the computing device to a remote device using a low level file transfer protocol. | 07-02-2015 |
20150341763 | ON HOLD DETECTION - A method includes detecting when a call is placed on hold on a call enabled device by another party on the call, performing an action via the call enabled device based on detection that the call has been placed on hold, and detecting when the call is taken off of hold. A user of the call enabled device may be notified when the call has been taken off of hold. | 11-26-2015 |
20150350450 | VIRTUAL CONFERENCE ROOM FOR TELEPHONIC CONFERENCING - In one aspect, a device includes a processor and a memory accessible to the processor. The memory bears instructions executable by the processor to engage in telephonic communication with at least a second device and a third device and, in response to input to the first device and without the first device concluding the telephonic communication with the second and third devices, enable auditory telephonic communication of the first device with the second device and prevent auditory telephonic communication of the first device with the third device. | 12-03-2015 |
20150355696 | COMPUTER PORT CONTROL - A system can include a processor; memory operatively coupled to the processor; a chipset operatively coupled to the processor; ports where each of the ports includes a respective power supply line; a switch; a hub operatively coupled to the ports and to the chipset for data transfer via an in-band protocol; and a microcontroller operatively coupled to the chipset, to the switch and to the hub where the microcontroller includes circuitry that controls the switch to transfer data to one of the ports via an out-of-band protocol and where the microcontroller includes circuitry that controls supply of power to the power supply lines. | 12-10-2015 |
20150356034 | EMBEDDED MICROCONTROLLER AND BUSES - A system can include a power supply unit; a processor; memory operatively coupled to the processor; a chipset operatively coupled to the processor; diagnostic information memory; and a microcontroller operatively coupled to the chipset via a first diagnostic data transfer bus and the microcontroller operatively coupled to the power supply unit and to the diagnostic information memory via a second diagnostic data transfer bus. | 12-10-2015 |
20160062780 | PAUSING VIRTUAL MACHINE BASED ON IDLE STATE - In one aspect, a device includes at least one processor and a memory accessible to the at least one processor. The memory bears instructions executable by the at least one processor to determine that a virtual machine (VM) at the device is in an at least partially idle state and pause the VM in response to the determination that the VM is in an at least partially idle state. | 03-03-2016 |
20160068099 | METHOD AND SYSTEM TO CONTROL VEHICLE TURN INDICATORS - Methods, systems and program products are provided for obtaining navigation data indicative of a present position of a vehicle and assessing lane restriction information in connection with a road lane corresponding to a present position of the vehicle as designated by the navigation data. The methods, systems and program products also activate a turn indicator of the vehicle based on the lane information and the navigation data. The methods, systems and program products collect navigation data indicative of a present position of a vehicle. | 03-10-2016 |
Patent application number | Description | Published |
20140186859 | AUTOFOCUS METHOD FOR IMAGING A BIOLOGICAL SAMPLE AND CARTRIDGE FOR USE THEREIN - A method of automatically focusing a microscope on a specimen is carried out by capturing an image from each of a plurality of focal planes in or on said specimen, calculating a focus score for each of said images, selecting the focal plane corresponding to the image having the best focus score, and then repositioning said specimen relative to said microscope so that said microscope is focused on said selected focal plane, the method includes a plurality of exogenous targets in or on said specimen, which aids in focusing in the event particular objects of interest, such as cells/pathogens that may or may not be in the sample, are not present, or are present in low numbers. Automated microscopes and microscope cartridges useful in such methods are also described, along with methods of detecting pathogens in biological samples. | 07-03-2014 |
20140233098 | DIAGNOSTIC APPARATUS - An automated microscope apparatus comprises an outer housing having an external wall; optionally but preferably an internal wall in the housing configured to form a first compartment and a separate second compartment in the outer housing; a microscope assembly in the housing (preferably in the first compartment); a microprocessor in the housing (preferably in the second compartment), and (optionally but preferably) a heat sink mounted on the housing external wall, preferably adjacent the second compartment, with the microprocessor thermally coupled to said heat sink and operatively associated with the microscope assembly. Systems and methods employing the same are also described, along with component parts thereof. | 08-21-2014 |
20140315283 | SAMPLE CARTRIDGE AND SAMPLE STAGE - A sample cartridge ( | 10-23-2014 |
20140363882 | RAPID DETECTION OF ANALYTES IN LIQUID SAMPLES - A device for detecting at least one analyte in a liquid sample generally comprises (i) a support having a chamber for receiving a biological fluid (e.g., milk) therein, wherein said chamber is an elongate chamber having a length axis; (ii) a (stationary or movable) carrier (in some embodiments in the form of an end cap, or connected to an end cap; in other embodiments in the form of an agitator in said elongate chamber). | 12-11-2014 |
20150037835 | SYSTEM AND METHOD FOR AUTOMATED DIAGNOSIS - An automated microscope apparatus comprises an outer housing having an external wall; optionally but preferably an internal wall in the housing configured to form a first compartment and a separate second compartment in the outer housing; a microscope assembly in the housing (preferably in the first compartment); a microprocessor in the housing (preferably in the second compartment), and (optionally but preferably) a heat sink mounted on the housing external wall, preferably adjacent the second compartment, with the microprocessor thermally coupled to said heat sink and operatively associated with the microscope assembly. Systems and methods employing the same are also described, along with component parts thereof. | 02-05-2015 |
Patent application number | Description | Published |
20100279174 | SECONDARY BATTERIES WITH TREATED BENTONITE CATHODES - Provided herein is an electrochemical cell for a secondary battery, which includes a positive electrode having an active intercalation cathode material of treated bentonite; a negative electrode material having an active anode material containing one of magnesium and sodium; an electrolyte positioned in contact with at least one of the positive electrode and the negative electrode; wherein, when the active anode material contains magnesium, the electrolyte is a solid gel polymeric electrolyte; and wherein, when the active anode material is sodium, the electrolyte is a salt electrolyte, both the anode material and the electrolyte are molten at the operating temperature of the battery, and the cell further comprises a beta alumina solid electrolyte separator between the negative electrode and the electrolyte. | 11-04-2010 |
20100279175 | SECONDARY BATTERIES WITH TREATED BENTONITE CATHODES HAVING ENHANCED CONDUCTIVITY - An electrochemical cell for a secondary battery is provided, which includes a positive electrode having an intercalation cathode material of bentonite; a negative electrode material having an anode material containing one of magnesium and sodium; an electrolyte positioned in contact with at least one of the positive electrode and the negative electrode; wherein, when the anode material contains magnesium, the electrolyte is a solid gel polymeric electrolyte; and wherein, when the anode material is sodium, the electrolyte is a salt electrolyte, both the anode material and the electrolyte are molten at the operating temperature of the battery, and the cell further comprises a beta alumina solid electrolyte separator between the negative electrode and the electrolyte. To increase its conductivity, the bentonite material is treated, before cell assembly, with an acid and/or intercalated with an anilinium ion, which is then polymerized to form a polyaniline within the bentonite framework. | 11-04-2010 |
Patent application number | Description | Published |
20100174810 | DISTRIBUTED PREBOOT EXECUTION ENVIRONMENT (PXE) SERVER BOOTING - A method, computer program product, and system are disclosed for distributed Preboot execution Environment (PXE) server booting. The method may include receiving a PXE boot image request from a plurality of target machines and sending one or more target machines a temporary PXE server RAM image and a subset of target machines. The temporary PXE server RAM image assigns a recipient target machine as a temporary PXE server and each temporary PXE server is delegated the subset of target machines to PXE boot. The method may also include receiving a subset boot confirmation from each temporary PXE server that indicates that the subset of target machines delegated to each temporary PXE server booted successfully. Finally, the method may include sending the one or more temporary PXE servers an agent boot image in response to the subset boot confirmation from each temporary PXE server. | 07-08-2010 |
20110276671 | DISTRIBUTED PREBOOT EXECUTION ENVIRONMENT (PXE) SERVER BOOTING - A computer program product and system are disclosed for distributed Preboot eXecution Environment (PXE) server booting. The computer program product may include an image request module configured to send a PXE boot image request to a master boot server; an assignment receiving module configured to receive a temporary PXE server RAM image and a subset of target machines from the master boot server, the temporary PXE server RAM image configured to assign a recipient target machine as a temporary PXE server, the temporary PXE server configured to agent boot the subset of target machines; a subset boot module configured to send each target machine in the subset of target machines an agent boot image; a subset confirmation module configured to receive a boot confirmation from each target machine, the boot confirmation configured to indicate that the target machine booted successfully; a master confirmation module configured to send a subset boot confirmation to the master boot server, the subset boot confirmation configured to indicate that the subset of target machines booted successfully; and an image receiving module configured to receive an agent boot image. | 11-10-2011 |
20150040217 | DATA PROTECTION IN A NETWORKED COMPUTING ENVIRONMENT - An approach for monitoring and protecting electronic data in a networked computing environment (e.g., a cloud computing environment) is provided. In a typical embodiment, an activity monitor gathers characteristics of data traffic of one or more virtual machines. The data traffic is analyzed to determine whether any of the data traffic is indicative of a malicious activity (e.g., unauthorized data transfers). If it appears a VM is engaging in malicious activity, then a counter for the VM is incremented by a predefined value that is associated with the malicious activity. When the counter for the VM exceeds a point threshold, a remediation action is taken with respect to the VM. | 02-05-2015 |
20150293762 | Smart Source Code Evaluation and Suggestion System - A method for s identifying program files within one or more programs that will likely require update to implement a proposed programming task is disclosed. A processor identifies a previous programming task that matches the proposed programming task. The processor also identifies a set of program files that were updated to implement the previous programming task. The processor then displays the set of program files or existing versions of the set of program files as program files that will likely require update for the proposed programming task. | 10-15-2015 |
20160034275 | CODING CONVENTION DISCOVERY AND ENFORCEMENT - In general, embodiments of the invention provide an approach to discover and enforce coding conventions among a group of developers. Specifically, source code files for a group of developers are imported from a code repository. The source code files are analyzed to discover the commonly used coding conventions of the group. Convention templates are generated based on these coding conventions. Each convention template is assigned a weighted value, and the convention templates are reviewed and approved based on the weighted value. | 02-04-2016 |
Patent application number | Description | Published |
20100319137 | STEPPED-EDGE AND SIDE-SUPPORT MEMBERS, ASSEMBLIES, SYSTEMS, AND RELATED METHODS, PARTICULARLY FOR BEDDING AND SEATING - Stepped-edge and side-support members, systems, assemblies, and related methods for an innerspring assembly or other core are disclosed. In one embodiment, an innerspring assembly or core is provided having an interior area of a first height surrounded by one or more exterior, perimeter area(s) of shorter height(s) to provide a stepped-edge innerspring assembly or core. At least a portion of side-support members are placed onto at least a portion of the top surface of the perimeter area to provide edge-support for the innerspring assembly or core. In this manner, a greater portion of the side-support members can be disposed in the sleeping area of the innerspring assembly or core since the underlying perimeter area provides spring support to the side-support members. Further, this support can assist in retention and/or recovery of the shape of the side-support members to further prevent or reduce compression set of the side-support members. | 12-23-2010 |
20110049327 | ASSEMBLIES, SYSTEMS, AND RELATED METHODS EMPLOYING INTERLOCKING COMPONENTS TO PROVIDE AT LEAST A PORTION OF AN ENCASEMENT, PARTICULARLY FOR BEDDING AND SEATING APPLICATIONS - Encasement assemblies, systems, and related methods employing interlocking support components to provide at least a portion of an encasement, particularly for bedding and seating applications, are disclosed. In this regard in one embodiment, an assembly for bedding or seating is provided. The assembly includes a base having one or more elongated channels disposed therein having a first geometry. The assembly also includes one or more elongated support members each having a rail disposed therein and having a second geometry complimentary to the first geometry. Each rail is interlocked with at least one of the one or more elongated channels such that the one or more elongated support members are attached to the base and extend from the base to provide at least a portion of an encasement. The assembly may also include a flip-up support member(s) disposed in the base to form at least a portion of the encasement. | 03-03-2011 |
20130081209 | CELLULAR MATTRESS ASSEMBLIES AND RELATED METHODS - Embodiments disclosed herein include cellular mattress assemblies and related methods. The cellular mattresses assemblies may comprise thermoplastic material and/or thermoset material to achieve appropriate comfort and support characteristics. The cellular mattress assemblies may also comprise one or more components including a cellular thermoplastic foam profile to achieve appropriate comfort and support characteristics. The cellular mattress may include a support layer, a comfort layer, and a transition layer between the support layer and the comfort layer. | 04-04-2013 |
20130174350 | MATTRESS ASSEMBLIES AND METHODS EMPLOYING CLOTH MEMBER(S) THERMALLY BONDED TO FOAM SIDE SUPPORT MEMBER(S) TO FORM MATTRESS ENCASEMENTS - Mattress assemblies and methods employing foam side support members and cloth members to enclose mattress cores are disclosed. A mattress may include a mattress assembly enclosing a mattress core. The foam side supports of the mattress assembly may be disposed adjacent to a periphery portion of the mattress core to provide additional support, for example, when a user mounts and dismounts from the mattress. The side support members may be thermally bonded to the cloth members to secure the side supports adjacent the periphery portion of the mattress core. In this manner, the side support members may be precisely positioned relative to the mattress core without the need for adhesives or expensive manufacturing equipment to thermally weld the side support members directly to a foam base. | 07-11-2013 |
20130232689 | BOX SPRING ASSEMBLIES EMPLOYING FOAM CUSHIONING GRIDS, AND RELATED COMPONENTS, MATTRESS ASSEMBLIES, AND METHODS - Box spring assemblies employing foam cushioning grids, and related components, mattress assemblies, and methods are disclosed. Foam cushioning grids are comprised of a plurality of foam grid members that are interconnected to form the foam cushioning grid. By interconnecting the foam grid members, a plurality of voids may be disposed between the interconnecting foam grid members as part of the foam cushioning grid. In this manner, as a non-limiting example, the foam cushioning grid can be disposed on a wire grid, such as in box springs, to provide cushioning support for the wire grid, as one non-limiting example. A load placed on the wire grid will be cushioned by the foam cushioning grid disposed therebetween. Further, as a non-limiting example, voids in the foam cushioning grid allow air to easily flow between the interconnected foam grid members. | 09-12-2013 |
20130263380 | INTERLOCKING FOAM ENCASEMENT COMPONENTS TO FORM MATTRESS ENCASEMENTS, AND RELATED MATTRESS ENCASEMENTS, MATTRESS ASSEMBLIES AND METHODS - Interlocking foam encasement components to form mattress encasements, and related mattress encasements, mattress assemblies, and methods are disclosed. A mattress encasement is formed by two interlocking foam encasement components engaged with each other. Each interlocking foam encasement component includes a foam base member with two foam side-support members provided in parallel or substantially parallel arrangement on opposite sides of the foam base member. To form the mattress encasement, first side-support members of a first interlocking foam encasement component are interlocked orthogonal or substantially orthogonal to second side-support members of a second interlocking foam encasement component to form a foam side-support perimeter for the mattress encasement. The foam side-support perimeter provides an interior area to receive and encase a mattress innerspring or mattress core. In this manner, as a non-limiting example, the mattress encasement can be easily assembled and the foam encasement members folded or rolled for reduced-volume storage and/or shipment. | 10-10-2013 |
20130283538 | MATTRESS ASSEMBLIES AND COMPONENTS EMPLOYING PASSAGEWAYS FOR VENTILATION AND AIRFLOW - Embodiments disclosed herein include mattress assemblies and components employing passageways for ventilation and airflow. A mattress may contain a mattress core to provide cushioning and support. For example, the mattress core may comprise an innerspring, air bladder(s), and/or foam layer(s). A mattress assembly may include a foam base and/or at least one foam side support member to at least partially surround a mattress core to provide cushioning and structure. The foam base and/or at least one foam side support member may include at least one passageway for facilitating diffusion and air exchange between an exterior environment and an interior space of the enclosure containing the mattress core. In this manner, as stagnant air and humidity developing in the mattress core may be avoided or reduced from the mattress core, which may otherwise cause unhealthy conditions or unpleasant odors for users. | 10-31-2013 |
20140130265 | ALL-FOAM MATTRESS ASSEMBLIES WITH FOAM ENGINEERED CORES HAVING THERMOPLASTIC AND THERMOSET MATERIALS, AND RELATED ASSEMBLIES AND METHODS - All-foam mattress assemblies with foam engineered cores having thermoplastic and thermoset materials, and related assemblies and methods are disclosed. All-foam mattress assemblies use foam-based materials, such as thermoplastic and thermoset, to provide cushioning and support characteristics for a user in the sleeping area of a mattress during sleep or rest. The all-foam mattress assemblies may include foam comfort layer(s), foam transitional layer(s), and a foam engineered core. The all-foam engineered core may lessen a density of a mattress assembly by comprising thermoset member(s), and engineered geometric thermoplastic material profile(s) adjacent to the thermoset member(s). The engineered geometric thermoplastic material profile(s) may be disposed in a parallel or substantially parallel arrangement. In this manner, the all-foam engineering core may provide cushioning and support characteristics with reduced density compared to a foam mattress providing similar cushioning and support through solid thermoset layers. | 05-15-2014 |